BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 171 filers reported holding BRIDGEBIO PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,753,687 | +39.1% | 749,097 | -9.3% | 0.00% | +100.0% |
| Q2 2023 | $14,202,178 | -37.2% | 825,708 | -39.5% | 0.00% | -50.0% |
| Q1 2023 | $22,632,646 | +251.2% | 1,365,057 | +61.4% | 0.00% | +100.0% |
| Q4 2022 | $6,445,088 | +21.1% | 845,812 | +58.0% | 0.00% | 0.0% |
| Q3 2022 | $5,322,000 | +4.7% | 535,329 | -4.4% | 0.00% | 0.0% |
| Q2 2022 | $5,084,000 | -55.9% | 559,931 | -50.7% | 0.00% | 0.0% |
| Q1 2022 | $11,531,000 | +10.9% | 1,136,071 | +82.2% | 0.00% | 0.0% |
| Q4 2021 | $10,402,000 | -54.5% | 623,660 | +27.8% | 0.00% | -50.0% |
| Q3 2021 | $22,875,000 | -30.8% | 488,044 | -10.0% | 0.00% | -33.3% |
| Q2 2021 | $33,066,000 | +143.7% | 542,437 | +146.3% | 0.00% | +50.0% |
| Q1 2021 | $13,569,000 | +114.3% | 220,270 | +147.3% | 0.00% | +100.0% |
| Q4 2020 | $6,333,000 | +358.2% | 89,060 | +141.8% | 0.00% | – |
| Q3 2020 | $1,382,000 | +91.9% | 36,828 | +66.8% | 0.00% | – |
| Q2 2020 | $720,000 | +21.2% | 22,080 | +7.9% | 0.00% | – |
| Q1 2020 | $594,000 | -57.6% | 20,459 | -48.8% | 0.00% | – |
| Q4 2019 | $1,401,000 | +1247.1% | 39,953 | +720.9% | 0.00% | – |
| Q3 2019 | $104,000 | – | 4,867 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $160,016,456 | 65.94% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $819,077,805 | 28.79% |
| Cormorant Asset Management, LP | 4,662,530 | $122,950,916 | 7.17% |
| Frazier Life Sciences Management, L.P. | 2,725,949 | $71,883,275 | 4.77% |
| Octagon Capital Advisors LP | 971,639 | $25,622,120 | 3.94% |
| M28 Capital Management LP | 121,200 | $3,196,044 | 3.66% |
| VIKING GLOBAL INVESTORS LP | 25,120,991 | $662,440,533 | 2.69% |
| BOONE CAPITAL MANAGEMENT LLC | 313,381 | $8,263,857 | 2.61% |
| Fernwood Investment Management, LLC | 235,620 | $6,213,299 | 2.23% |
| SOUTHPORT MANAGEMENT, L.L.C. | 15,000 | $395,550 | 2.15% |